Plasticity of gastro-intestinal vagal afferent endings

Physiology and Behavior

Volumn 136, Issue , 2014, Pages 170-178

  Kentish, Stephen J ^a   Page, Amanda J ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Microbiota; Nutrients; Obesity; Peptides; Plasticity; Vagal afferents

Indexed keywords

CHOLECYSTOKININ; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; PEPTIDE YY;

ANATOMY; ARTICLE; CIRCADIAN RHYTHM; GASTROINTESTINAL VAGAL AFFERENT ENDING; HUMAN; INTESTINE FLORA; INTRAGANGLIONIC LAMINAR ENDING; NERVE CELL PLASTICITY; NERVE ENDING; NUTRIENT; OBESITY; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 84917743584     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.03.012     Document Type: Article

References (160)

1. Toouli J., Collins J., Wray N., Billington C., Knudson M., Pulling C., et al. Vagal blocking for obesity control. Obes Surg 2007, 17:1043.
2. Andrews P.L.R., Sanger G.J. Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. Curr Opin Pharmacol 2002, 2:650-656.
3. Hausken T., Svebak S., Wilhelmsen I., Haug T.T., Olafsen K., Pettersson E., et al. Low vagal tone and antral dysmotility in patients with functional dyspepsia. Psychosom Med 1993, 55:12-22.
4. Holtmann G., Goebell H., Jockenhoevel F., Talley N.J. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia. Gut 1998, 42:501-506.
5. Hong D., Kamath M., Wang S., Tabet J., Tougas G., Anvari M. Assessment of the afferent vagal nerve in patients with gastroesophageal reflux. Surg Endosc 2002, 16:1042-1045.
6. Mizrahi M., Ben Ya'acov A., Ilan Y. Gastric stimulation for weight loss. World J Gastroenterol 2012, 18:2309-2319.
7. Agostoni E., Chinnock J.E., Daly M.D.B., Murray J. Functional and histological studies of the vagus nerve and its branches to the heart, lung and abdominal viscera in the cat. J Physiol 1957, 135:182-205.
8. Babic T., Browning K.N. The role of vagal neurocircuits in the regulation of nausea and vomiting. Eur J Pharmacol 2014, 722:38-47.
9. Browning K.N., Travagli R.A. Plasticity of vagal brainstem circuits in the control of gastrointestinal function. Auton Neurosci 2011, 161:6-13.
10. Nonidez J.F. Afferent nerve endings in the ganglia of the intermuscular plexus of the dog's oesophagus. J Comp Neurol 1946, 85:177-189.
11. Berthoud H.R., Blackshaw L.A., Brookes S.J.H., Grundy D. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 2004, 16:28-33.
12. Kentish S.J., O'Donnell T.A., Isaacs N.J., Young R.L., Li H., Harrington A.M., et al. Gastric vagal afferent modulation by leptin is influenced by food intake status. J Physiol 2013, 591:1921-1934.
13. Rodrigo J., de Felipe J., Robles-Chillida E.M., Perez Anton J.A., Mayo I., Gomez A. Sensory vagal nature and anatomical access paths to esophagus laminar nerve endings in myenteric ganglia. Determination by surgical degeneration methods. Acta Anat 1982, 112:47-57.
14. Berthoud H.R., Powley T.L. Vagal afferent innervation of the rat fundic stomach: morphological characterization of the gastric tension receptor. J Comp Neurol 1992, 319:261-276.
15. Berthoud H.R., Patterson L.M., Neumann F., Neuhuber W.L. Distribution and structure of vagal afferent intraganglionic laminar endings (IGLEs) in the rat gastrointestinal tract. Anat Embryol 1997, 195:183-191.
16. Iggo A. Tension receptors in the stomach and the urinary bladder. J Physiol 1955, 128:593-607.
17. Blackshaw L.A., Grundy D., Scratcherd T. Vagal afferent discharge from gastric mechanoreceptors during contraction and relaxation of the ferret corpus. J Auton Nerv Syst 1987, 18:19-24.
18. Zagorodnyuk V.P., Chen B.N., Brookes S.J.H. Intraganglionic laminar endings are mechano-transduction sites of vagal tension receptors in the guinea-pig stomach. J Physiol 2001, 534:255-268.
19. Andrews P.L., Grundy D., Scratcherd T. Vagal afferent discharge from mechanoreceptors in different regions of the ferret stomach. J Physiol 1980, 298:513-524.
20. Wang F.B., Powley T.L. Topographic inventories of vagal afferents in gastrointestinal muscle. J Comp Neurol 2000, 421:302-324.
21. Powley T.L., Wang X.y., Fox E.A., Phillips R.J., Liu L.W.C., Huizinga J.D. Ultrastructural evidence for communication between intramuscular vagal mechanoreceptors and interstitial cells of Cajal in the rat fundus. Neurogastroenterol Motil 2008, 20:69-79.
22. Powley T.L., Phillips R.J. Vagal intramuscular array afferents form complexes with interstitial cells of Cajal in gastrointestinal smooth muscle: analogues of muscle spindle organs?. Neuroscience 2011, 186:188-200.
23. Phillips R.J., Powley T.L. Tension and stretch receptors in gastrointestinal smooth muscle: re-evaluating vagal mechanoreceptor electrophysiology. Brain Res Rev 2000, 34:1-26.
24. Page A.J., Blackshaw L.A. An in vitro study of the properties of vagal afferent fibres innervating the ferret oesophagus and stomach. J Physiol 1998, 512:907-916.
25. Page A.J., Martin C.M., Blackshaw L.A. Vagal mechanoreceptors and chemoreceptors in mouse stomach and esophagus. J Neurophysiol 2002, 87:2095-2103.
26. Berthoud H.-R., Kressel M., Raybould H., Neuhuber W. Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing. Anat Embryol 1995, 191:203-212.
27. Powley T.L., Spaulding R.A., Haglof S.A. Vagal afferent innervation of the proximal gastrointestinal tract mucosa: chemoreceptor and mechanoreceptor architecture. J Comp Neurol 2011, 519:644-660.
28. Gautron L., Sakata I., Udit S., Zigman J.M., Wood J.N., Elmquist J.K. Genetic tracing of Nav1.8-expressing vagal afferents in the mouse. J Comp Neurol 2011, 519:3085-3101.
29. Clarke G.D., Davison J.S. Mucosal receptors in the gastric antrum and small intestine of the rat with afferent fibres in the cervical vagus. J Physiol 1978, 284:55-67.
30. Becker J.M., Kelly K.A. Antral control of canine gastric emptying of solids. Am J Physiol 1983, 8:G334-G338.
31. Andrews P.L., Wood K.L. Vagally mediated gastric motor and emetic reflexes evoked by stimulation of the antral mucosa in anaesthetized ferrets. J Physiol 1988, 395:1-16.
32. Webster W.A., Beyak M.J. The long chain fatty acid oleate activates mouse intestinal afferent nerves in vitro. Can J Physiol Pharmacol 2013, 91:375-379.
33. Randich A., Tyler W.J., Cox J.E., Meller S.T., Kelm G.R., Bharaj S.S. Responses of celiac and cervical vagal afferents to infusions of lipids in the jejunum or ileum of the rat. Am J Physiol 2000, 278:R34-R43.
34. Cox J.E., Kelm G.R., Meller S.T., Randich A. Suppression of food intake by GI fatty acid infusions: roles of celiac vagal afferents and cholecystokinin. Physiol Behav 2004, 82:27-33.
35. Liou A.P., Lu X., Sei Y., Zhao X., Pechhold S., Carrero R.J., et al. The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology 2011, 140:903-12.e4.
36. Ogawa N., Yamaguchi H., Shimbara T., Toshinai K., Kakutani M., Yonemori F., et al. The vagal afferent pathway does not play a major role in the induction of satiety by intestinal fatty acid in rats. Neurosci Lett 2008, 433:38-42.
37. Bryant M.G., Bloom S.R. Distribution of the gut hormones in the primate intestinal tract. Gut 1979, 20:653-659.
38. Cummings D.E., Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007, 117:13-23.
39. Peterli R., Steinert R.E., Woelnerhanssen B., Peters T., Christoffel-Courtin C., Gass M., et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg 2012, 22:740-748.
40. Jacobsen S.H., Olesen S.C., Dirksen C., Jorgensen N.B., Bojsen-Moller K.N., Kielgast U., et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2weeks after gastric bypass in non-diabetic subjects. Obes Surg 2012, 22:1084-1096.
41. Gamble J., Kenny S., Dockray G.J. Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice. Regul Pept 2013, 185:9-13.
42. Covasa M., Ritter R.C. Adaptation to high-fat diet reduces inhibition of gastric emptying by CCK and intestinal oleate. Am J Physiol 2000, 278:R166-R170.
43. Jordi J., Herzog B., Camargo S.M., Boyle C.N., Lutz T.A., Verrey F. Specific amino acids inhibit food intake via the area postrema or vagal afferents. J Physiol 2013, 591:5611-5621.
44. Browning K.N., Babic T., Holmes G.M., Swartz E., Travagli R.A. A critical re-evaluation of the specificity of action of perivagal capsaicin. J Physiol 2013, 591:1563-1580.
45. Berthoud H.R., Patterson L.M., Willing A.E., Mueller K., Neuhuber W.L. Capsaicin-resistant vagal afferent fibers in the rat gastrointestinal tract: anatomical identification and functional integrity. Brain Res 1997, 746:195-206.
46. Höfer D., Püschel B., Drenckhahn D. Taste receptor-like cells in the rat gut identified by expression of alpha-gustducin. Proc Natl Acad Sci U S A 1996, 93:6631-6634.
47. Hass N., Schwarzenbacher K., Breer H. T1R3 is expressed in brush cells and ghrelin-producing cells of murine stomach. Cell Tissue Res 2010, 339:493-504.
48. Haid D., Widmayer P., Breer H. Nutrient sensing receptors in gastric endocrine cells. J Mol Histol 2011, 42:355-364.
49. Uneyama H., Niijima A., San Gabriel A., Torii K. Luminal amino acid sensing in the rat gastric mucosa. Am J Physiol 2006, 291:G1163-G1170.
50. Janssen P., Verschueren S., Tack J. Intragastric pressure as a determinant of food intake. Neurogastroenterol Motil 2012, 24:612-e268.
51. Grabauskas G., Zhou S.-Y., Lu Y., Song I., Owyang C. Essential elements for glucosensing by gastric vagal afferents: immunocytochemistry and electrophysiology studies in the rat. Endocrinology 2013, 154:296-307.
52. Grabauskas G., Song I., Zhou S., Owyang C. Electrophysiological identification of glucose-sensing neurons in rat nodose ganglia. J Physiol 2010, 588:617-632.
53. Ritzel U., Fromme A., Ottleben M., Leonhardt U., Ramadori G. Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum. Acta Diabetol 1997, 34:18-21.
54. Drapanas T., McDonald J.C., Stewart J.D. Serotonin release following instillation of hypertonic glucose into the proximal intestine. Ann Surg 1962, 156:528-536.
55. Blouet C., Schwartz G.J. Duodenal lipid sensing activates vagal afferents to regulate non-shivering brown fat thermogenesis in rats. PLoS One 2012, 7:e51898.
56. Nagai N., Sakane N., Ueno L.M., Hamada T., Moritani T. The -3826 A→G variant of the uncoupling protein-1 gene diminishes postprandial thermogenesis after a high fat meal in healthy boys. J Clin Endocrinol Metab 2003, 88:5661-5667.
57. Osaka T., Kobayashi A., Inoue S. Vago-sympathoadrenal reflex in thermogenesis induced by osmotic stimulation of the intestines in the rat. J Physiol 2002, 540:665-671.
58. Mei N., Garnier L. Osmosensitive vagal receptors in the small intestine of the cat. J Auton Nerv Syst 1986, 16:159-170.
59. Phillips R.J., Powley T.L. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol 1996, 271:R766-R769.
60. Raybould H., Gayton R., Dockray G. Mechanisms of action of peripherally administered cholecystokinin octapeptide on brain stem neurons in the rat. J Neurosci 1988, 8:3018-3024.
61. Frederich R.C., Hamann A., Anderson S., Lollmann B., Lowell B.B., Flier J.S. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1995, 1:1311-1314.
62. Bado A., Levasseur S., Attoub S., Kermorgant S., Laigneau J., Bortoluzzi M.I., et al. The stomach is a source of leptin. Nature 1998, 394:790-793.
63. Peiser C., Springer J., Groneberg D.A., McGregor G.P., Fischer A., Lang R.E. Leptin receptor expression in nodose ganglion cells projecting to the rat gastric fundus. Neurosci Lett 2002, 320:41-44.
64. Peters J.H., Karpiel A.B., Ritter R.C., Simasko S.M. Cooperative activation of cultured vagal afferent neurons by leptin and cholecystokinin. Endocrinology 2004, 145:3652-3657.
65. Peters J.H., Ritter R.C., Simasko S.M. Leptin and CCK selectively activate vagal afferent neurons innervating the stomach and duodenum. Am J Physiol 2006, 290:R1544-R1549.
66. Peters J.H., McKay B.M., Simasko S.M., Ritter R.C. Leptin-induced satiation mediated by abdominal vagal afferents. Am J Physiol 2005, 288:879-884.
67. Patel J.D., Ebenezer I.S. The effect of intraperitoneal administration of leptin on short-term food intake in rats. Eur J Pharmacol 2008, 580:143-152.
68. Sachot C., Rummel C., Bristow A.F., Luheshi G.N. The role of the vagus nerve in mediating the long-term anorectic effects of leptin. J Neuroendocrinol 2007, 19:250-261.
69. Münzberg H., Flier J.S., Bjørbæk C. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 2004, 145:4880-4889.
70. de Lartigue G., Barbier de la Serre C., Espero E., Lee J., Raybould H.E. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol 2011, 301:E187-E195.
71. de Lartigue G., Barbier de la Serre C., Espero E., Lee J., Raybould H.E. Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats. PLoS One 2012, 7:e32967.
72. Kentish S.J., O'Donnell T.A., Frisby C.L., Li H., Wittert G.A., Page A.J. Altered gastric vagal mechanosensitivity in diet-induced obesity persists on return to normal chow and is accompanied by increased food intake. Int J Obes 2013, 10.1038/ijo.2013.138.
73. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141:4255-4261.
74. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141:4325-4328.
75. Yang J., Brown M.S., Liang G., Grishin N.V., Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008, 132:387-396.
76. Burdyga G., Varro A., Dimaline R., Thompson D.G., Dockray G.J. Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance. Am J Physiol 2006, 290:G1289-G1297.
77. Page A.J., Slattery J.A., Milte C., Laker R., O'Donnell T., Dorian C., et al. Ghrelin selectively reduces mechanosensitivity of upper gastrointestinal vagal afferents. Am J Physiol 2007, 292:G1376-G1384.
78. Murray C.D.R., Booth C.E., Bulmer D.C.E., Kamm M.A., Emmanuel A.V., Winchester W.J. Ghrelin augments afferent response to distension in rat isolated jejunum. Neurogastroenterol Motil 2006, 18:1112-1120.
79. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
80. Arnold M., Mura A., Langhans W., Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci 2006, 26:11052-11060.
81. Briggs D.I., Enriori P.J., Lemus M.B., Cowley M.A., Andrews Z.B. Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 2010, 151:4745-4755.
82. Druce M.R., Wren A.M., Park A.J., Milton J.E., Patterson M., Frost G., et al. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes 2005, 29:1130-1136.
83. Shearman L.P., Wang S.-P., Helmling S., Stribling D.S., Mazur P., Ge L., et al. Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice. Endocrinology 2006, 147:1517-1526.
84. Kentish S., Li H., Philp L.K., O'Donnell T.A., Isaacs N.J., Young R.L., et al. Diet-induced adaptation of vagal afferent function. J Physiol 2012, 590:209-221.
85. Rehfeld J.F. Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem 1978, 253:4022-4030.
86. Liou A.P., Sei Y., Zhao X., Feng J., Lu X., Thomas C., et al. The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to l-phenylalanine in acutely isolated intestinal I cells. Am J Physiol 2011, 300:G538-G546.
87. Brennan I.M., Little T.J., Feltrin K.L., Smout A.J., Wishart J.M., Horowitz M., et al. Dose-dependent effects of cholecystokinin-8 on antropyloroduodenal motility, gastrointestinal hormones, appetite, and energy intake in healthy men. Am J Physiol 2008, 295:E1487-E1494.
88. Sullivan C.N., Raboin S.J., Gulley S., Sinzobahamvya N.T., Green G.M., Reeve J.R., et al. Endogenous cholecystokinin reduces food intake and increases Fos-like immunoreactivity in the dorsal vagal complex but not in the myenteric plexus by CCK1 receptor in the adult rat. Am J Physiol 2007, 292:R1071-R1080.
89. Burdyga G., Lal S., Varro A., Dimaline R., Thompson D.G., Dockray G.J. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J Neurosci 2004, 24:2708-2715.
90. Paulino G., Barbier de la Serre C., Knotts T.A., Oort P.J., Newman J.W., Adams S.H., et al. Increased expression of receptors for orexigenic factors in nodose ganglion of diet-induced obese rats. Am J Physiol 2009, 296:E898-E903.
91. Duca F.A., Swartz T.D., Sakar Y., Covasa M. Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors. Int J Obes 2013, 37:375-381.
92. de Lartigue G., Dimaline R., Varro A., Raybould H., De La Serre C.B., Dockray G.J. Cocaine- and amphetamine-regulated transcript mediates the actions of cholecystokinin on rat vagal afferent neurons. Gastroenterology 2010, 138:1479-1490.
93. Burdyga G., Lal S., Spiller D., Jiang W., Thompson D., Attwood S., et al. Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans. Gastroenterology 2003, 124:129-139.
94. Burdyga G., Varro A., Dimaline R., Thompson D.G., Dockray G.J. Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype. Am J Physiol 2010, 299:G63-G69.
95. Covasa M., Ritter R.C. Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin. Peptides 1998, 19:1407-1415.
96. Daly D.M., Park S.J., Valinsky W.C., Beyak M.J. Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol 2011, 589:2857-2870.
97. Lee Y.C., Brubaker P.L., Drucker D.J. Developmental and tissue-specific regulation of proglucagon gene expression. Endocrinology 1990, 127:2217-2222.
98. Elliott R.M., Morgan L.M., Tredger J.A., Deacon S., Wright J., Marks V. Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993, 138:159-166.
99. Cordier-Bussat M., Bernard C., Levenez F., Klages N., Laser-Ritz B., Philippe J., et al. Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene. Diabetes 1998, 47:1038-1045.
100. Gutzwiller J.-P., Göke B., Drewe J., Hildebrand P., Ketterer S., Handschin D., et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999, 44:81-86.
101. Fridolf T., Ahren B. GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action. Diabetes Res 1991, 16:185-191.
102. Drucker D.J. The biology of incretin hormones. Cell Metab 2006, 3:153-165.
103. Delgado-Aros S., Kim D.-Y., Burton D.D., Thomforde G.M., Stephens D., Brinkmann B.H., et al. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol 2002, 282:G424-G431.
104. Gaisano G.G., J.Park S., Daly D.M., Beyak M.J. Glucagon-like peptide-1 inhibits voltage-gated potassium currents in mouse nodose ganglion neurons. Neurogastroenterol Motil 2010, 22:470-e111.
105. Hayes M.R., Kanoski S.E., De Jonghe B.C., Leichner T.M., Alhadeff A.L., Fortin S.M., et al. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1. Am J Physiol 2011, 301:R1479-R1485.
106. Rüttimann E.B., Arnold M., Hillebrand J.J., Geary N., Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 2009, 150:1174-1181.
107. Bucinskaite V., Tolessa T., Pedersen J., Rydqvist B., Zerihun L., Holst J.J., et al. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol Motil 2009, 21:978-e78.
108. Nakagawa A., Satake H., Nakabayashi H., Nishizawa M., Furuya K., Nakano S., et al. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci 2004, 110:36-43.
109. Washington M.C., Raboin S.J., Thompson W., Larsen C.J., Sayegh A.I. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor. Brain Res 2010, 1344:124-133.
110. Meier J.J., Nauck M.A., Kranz D., Holst J.J., Deacon C.F., Gaeckler D., et al. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Diabetes 2004, 53:654-662.
111. 2+ in rat nodose ganglion neurons. Auton Neurosci 2002, 102:39-44.
112. Duca F.A., Sakar Y., Covasa M. Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist exendin-4. Diabetes 2013, 62:2410-2415.
113. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985, 89:1070-1077.
114. Greeley G.H., Jeng Y.J., Gomez G., Hashimoto T., Hill F.L., Kern K., et al. Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology 1989, 124:1438-1443.
115. Pilichiewicz A.N., Papadopoulos P., Brennan I.M., Little T.J., Meyer J.H., Wishart J.M., et al. Load-dependent effects of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol 2007, 293:R2170-R2178.
116. Karra E., Chandarana K., Batterham R.L. The role of peptide YY in appetite regulation and obesity. J Physiol 2009, 587:19-25.
117. Batterham R.L., Heffron H., Kapoor S., Chivers J.E., Chandarana K., Herzog H., et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 2006, 4:223-233.
118. MacIntosh C.G., Andrews J.M., Jones K.L., Wishart J.M., Morris H.A., Jansen J.B., et al. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. Am J Clin Nutr 1999, 69:999-1006.
119. Grandt D., Schimiczek M., Beglinger C., Layer P., Goebell H., Eysselein V.E., et al. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 1994, 51:151-159.
120. Mentlein R., Dahms P., Grandt D., Kruger R. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 1993, 49:133-144.
121. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418:650-654.
122. Koda S., Date Y., Murakami N., Shimbara T., Hanada T., Toshinai K., et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 2005, 146:2369-2375.
123. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005, 1044:127-131.
124. Burdyga G., de Lartigue G., Raybould H.E., Morris R., Dimaline R., Varro A., et al. Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach. J Neurosci 2008, 28:11583-11592.
125. Broberger C., Landry M., Wong H., Walsh J.N., Hokfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 1997, 66:393-408.
126. Scott V., Kimura N., Stark J.A., Luckman S.M. Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour. J Neuroendocrinol 2005, 17:452-457.
127. Naveilhan P., Hassani H., Canals J.M., Ekstrand A.J., Larefalk A., Chhajlani V., et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat Med 1999, 5:1188-1193.
128. le Roux C.W., Batterham R.L., Aylwin S.J.B., Patterson M., Borg C.M., Wynne K.J., et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006, 147:3-8.
129. Rahardjo G.L., Huang X.-F., Tan Y.Y., Deng C. Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice. Endocrinology 2007, 148:4704-4710.
130. Pendergast J.S., Branecky K.L., Yang W., Ellacott K.L.J., Niswender K.D., Yamazaki S. High-fat diet acutely affects circadian organisation and eating behavior. Eur J Neurosci 2013, 37:1350-1356.
131. Coomans C.P., van den Berg S.A.A., Lucassen E.A., Houben T., Pronk A.C.M., van der Spek R.D., et al. The suprachiasmatic nucleus controls circadian energy metabolism and hepatic insulin sensitivity. Diabetes 2013, 62:1102-1108.
132. Stephan F.K., Swann J.M., Sisk C.L. Anticipation of 24-hr feeding schedules in rats with lesions of the suprachiasmatic nucleus. Behav Neural Biol 1979, 25:346-363.
133. Kentish S.J., Frisby C.L., Kennaway D.J., Wittert G.A., Page A.J. Circadian variation in gastric vagal afferent mechanosensitivity. J Neurosci 2013, 33:19238-19242.
134. Rosenwasser A.M., Boulos Z., Terman M. Circadian organization of food intake and meal patterns in the rat. Physiol Behav 1981, 27:33-39.
135. Wang G., Tomasi D., Backus W., Wang R., Telang F., Geliebter A., et al. Gastric distention activates satiety circuitry in the human brain. Neuroimage 2008, 39:1824-1831.
136. Gschossmann J.M., Buenger L., Adam B., Liebregts T., Saller B., Mann K., et al. Diurnal variation of abdominal motor responses to colorectal distension and plasma cortisol levels in rats. Neurogastroenterol Motil 2001, 13:585-589.
137. Pan X., Munshi M.K., Iqbal J., Queiroz J., Sirwi A.A., Shah S., et al. Circadian regulation of intestinal lipid absorption by apolipoprotein AIV involves forkhead transcription factors A2 and O1 and microsomal triglyceride transfer protein. J Biol Chem 2013, 288:20464-20476.
138. Castello A., Guma A., Sevilla L., Furriols M., Testar X., Palacin M., et al. Regulation of GLUT5 gene expression in rat intestinal mucosa: regional distribution, circadian rhythm, perinatal development and effect of diabetes. Biochem J 1995, 309(Pt 1):271-277.
139. Bhutta H., Deelman T., Ashley S., Rhoads D., Tavakkoli A. Disrupted circadian rhythmicity of the intestinal glucose transporter SGLT1 in Zucker diabetic fatty rats. Dig Dis Sci 2013, 58:1537-1545.
140. Qandeel H., Alonso F., Hernandez D., Duenes J., Zheng Y., Scow J., et al. Role of vagal innervation in diurnal rhythm of intestinal peptide transporter 1 (PEPT1). J Gastrointest Surg 2009, 13:1976-1985.
141. Goo R.H., Moore J.G., Greenberg E., Alazraki N.P. Circadian variation in gastric emptying of meals in humans. Gastroenterology 1987, 93:515-518.
142. Trout D.L., King S.A., Bernstein P.A., Halberg F., Cornelissen G. Circadian variation in the gastric-emptying response to eating in rats previously fed once or twice daily. Chronobiol Int 1991, 8:14-24.
143. Aviv R., Policker S., Brody F., Bitton O., Haddad W., Kliger A., et al. Circadian patterns of gastric electrical and mechanical activity in dogs. Neurogastroenterol Motil 2008, 20:63-68.
144. Evans J.M., Morris L.S., Marchesi J.R. The gut microbiome: the role of a virtual organ in the endocrinology of the host. J Endocrinol 2013, 218:R37-R47.
145. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
146. Tolhurst G., Heffron H., Lam Y.S., Parker H.E., Habib A.M., Diakogiannaki E., et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012, 61:364-371.
147. Lal S., Kirkup A.J., Brunsden A.M., Thompson D.G., Grundy D. Vagal afferent responses to fatty acids of different chain length in the rat. Am J Physiol 2001, 281:G907-G915.
148. Roy C.C., Kien C.L., Bouthillier L., Levy E. Short-chain fatty acids: ready for prime time?. Nutr Clin Pract 2006, 21:351-366.
149. Bergman E.N. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 1990, 70:567-590.
150. Hansen C.F., Vrang N., Sangild P.T., Jelsing J. Novel insight into the distribution of L-cells in the rat intestinal tract. Am J Transl Res 2013, 5:347-358.
151. Hosoi T., Okuma Y., Matsuda T., Nomura Y. Novel pathway for LPS-induced afferent vagus nerve activation: possible role of nodose ganglion. Auton Neurosci 2005, 120:104-107.
152. Aubert A., Kelley K.W., Dantzer R. Differential effect of lipopolysaccharide on food hoarding behavior and food consumption in rats. Brain Behav Immun 1997, 11:229-238.
153. Gakis G., Mueller M.H., Hahn J., Glatzle J., Grundy D., Kreis M.E. Neuronal activation in the nucleus of the solitary tract following jejunal lipopolysaccharide in the rat. Auton Neurosci 2009, 148:63-68.
154. Riley T.P., Neal-McKinney J.M., Buelow D.R., Konkel M.E., Simasko S.M. Capsaicin-sensitive vagal afferent neurons contribute to the detection of pathogenic bacterial colonization in the gut. J Neuroimmunol 2013, 257:36-45.
155. Schwartz G.J., Plata-Salaman C.R., Langhans W. Subdiaphragmatic vagal deafferentation fails to block feeding-suppressive effects of LPS and IL-1 beta in rats. Am J Physiol 1997, 273:R1193-R1198.
156. Liu C.Y., Mueller M.H., Grundy D., Kreis M.E. Vagal modulation of intestinal afferent sensitivity to systemic LPS in the rat. Am J Physiol 2007, 292:G1213-G1220.
157. de La Serre C.B., Ellis C.L., Lee J., Hartman A.L., Rutledge J.C., Raybould H.E. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol 2010, 299:G440-G448.
158. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
159. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
160. Murphy E.F., Cotter P.D., Healy S., Marques T.M., O'Sullivan O., Fouhy F., et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010, 59:1635-1642.